Middle East respiratory syndrome coronavirus (MERS-CoV)
9 March 2018 - WHO has developed a special tool to identify pathogens that pose a public health risk because of their epidemic potential and for which there are no, or insufficient, countermeasures. The diseases identified through this process are the focus of the work of R&D Blueprint.
The 2nd annual review was carried out on 6-7 February 2018, and the list of blueprint priority diseases includes: Crimean-Congo haemorrhagic fever, Ebola virus disease and Marburg virus disease, Lassa fever, MERS-CoV, SARS, Nipah and henipaviral diseases, Rift Valley fever, Zika virus disease and disease X.
MERS situation update from the Eastern Mediterranean Region
29 January 2018 - WHO conducts regular global and regional assessments of MERS-CoV. Improved infection prevention and control practices in health care facilities has led to a significant drop in the number of healthcare-associated outbreaks of MERS-CoV compared to previous years.
27 September 2017 -- Critical next steps to accelerate the response to the global public health threat posed by MERS-CoV have been agreed by representatives from the Ministries of Health and Ministries of Agriculture of affected and at risk countries, and experts. The virus, which circulates in dromedary camels without causing visible disease, can be fatal for humans.
Latest WHO MERS-CoV global summary and assessment of risk
July 2017 -- Between 2012 and 21 July 2017, 2040 laboratory-confirmed cases of Middle East respiratory syndrome-coronavirus (MERS-CoV) infection were reported to WHO, 82% of whom were reported by the Kingdom of Saudi Arabia. In total, cases have been reported from 27 countries in the Middle East, North Africa, Europe, the United States of America, and Asia. Thus far, no sustained human-to-human transmission has occurred anywhere in the world, however limited non-sustained human-to-human transmission in health-care facilities remains a prominent feature of this virus. WHO continues to work with health authorities in the affected countries.
WHO publishes MERS-CoV vaccine product profile
New standards for vaccines for MERS-CoV – which has so far killed at least 693 people – have been set by WHO and partners. The “WHO Target Product Profiles for MERS-CoV Vaccines” describes minimum acceptable standards for three vaccines currently under development: one vaccine intended to prevent transmission of this virus from dromedary camels to people; and two vaccines for use in outbreaks of this deadly disease and for longer-term protection of people at high risk.
Introductory level online course on MERS
Middle East respiratory syndrome (MERS) is a viral respiratory illness caused by a coronavirus (Middle East respiratory syndrome coronavirus, or MERS-CoV).
A new course on MERS is hosted by the new OpenWHO learning platform and consists of 4 interactive modules featuring video lectures, presentations and self-tests. The course is aimed to provide information about what is known about this virus, the disease it causes and the ways to prevent, respond to, and control outbreaks of MERS.
2,144Since September 2012, WHO has been notified of 2,144 laboratory-confirmed cases of infection with MERS-CoV.For more: Latest disease outbreak news
750WHO has been notified of at least 750 deaths related to MERS-CoV since September 2012.For more: Coronavirus infections news
27Since September 2012, 27 countries have reported cases of MERS-CoVFor more: Fact sheet on MERS-CoV
Updates on MERS-CoV
- Disease outbreak news
- Fact sheet on MERS-CoV
- Frequently asked questions
- Press releases
- Briefing notes
Latest regional update for MERS-CoV
Maps and epicurves
Epicurve of confirmed global cases of MERS-CoV
Global map of countries with confirmed cases of MERS-CoV
Middle East respiratory syndrome coronavirus (MERS-CoV) – Oman
Middle East respiratory syndrome coronavirus (MERS-CoV) – Saudi Arabia
Middle East respiratory syndrome coronavirus (MERS-CoV) – Malaysia
Middle East respiratory syndrome coronavirus (MERS-CoV) – United Arab Emirates
Revised case definition for reporting to WHO - Middle East respiratory syndrome coronavirus
Laboratory testing for Middle East Respiratory Syndrome Coronavirus
Interim Case Summary Form for rapid reporting of probable and confirmed cases of MERS-CoV infection to WHO
Management of Asymptomatic Persons
Update on MERS-CoV transmission from animals to humans, and interim recommendations for at-risk groups
Technical guidance by topic
Emergency Committee on MERS-CoV
WHO statement on the tenth meeting of the IHR Emergency Committee regarding MERS
WHO statement on the ninth meeting of the IHR Emergency Committee regarding MERS-CoV
- Read about the IHR Emergency Committee on MERS-CoV
- Read more on general information on IHR Emergency Committee